SynthesisFrontiers in cardiovascular medicine2025

From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy.

Rade Jibawi Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.